We need your support. Know More
Politics
No Need to Ban International Flights or Impose Lockdown Under Present COVID Scenario: Experts
Past experiences show that banning flights is not effective in halting the transmission of infection, former AIIMS Delhi director Randeep Guleria said.
Science
Bharat Biotech Must Address WHO’s Covaxin Suspension To Avoid Losing EUL: MEA
Science
Gap Between Second and Booster Dose of COVID Vaccine Will Soon Be 6 Months
Science
Govt Panel Recommends EUA for Corbevax for Those Aged 5 to 11 Years
Science
Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin
Politics
Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin
The recommendations will now be sent to the DCGI for final approval.
Science
COVID-19: Govt Panel Recommends EUA for Covovax, Corbevax and Molnupiravir
Science
For Now, Covaxin Likely To Be Sole COVID Vaccine for 15-18 Year Olds
Science
DCGI Okays Covaxin For Young Adults Aged 12-18 Years, With Some Conditions
Top Stories
WHO Grants Emergency Use Listing to Bharat Biotech’s Covaxin
This comes after the Technical Advisory Group (TAG), an independent advisory committee of the WHO, recommended EUL status for Covaxin.
Science
WHO Panel Recommends Emergency Use Listing for Bharat Biotech’s Covaxin
Science
WHO Grants Emergency Use Listing to Bharat Biotech’s Covaxin
Science
Serum Institute Seeks DCGI Nod for COVID Vaccine ‘Covovax’
Politics
Expert Panel Recommends Emergency Use Approval for Covaxin in 2 to 18 Age Group
The recommendations have been forwarded to the Drugs Controller General of India for final approval.
Politics
DCGI Allows Biological E To Proceed With Phase 2, 3 Trials of Its COVID Vaccine
The trial will be conducted across 10 sites in the country.
Science
DCGI Allows Biological E To Proceed With Phase 2, 3 Trials of Its COVID Vaccine
Science
Sewage Samples To Be Collected To Assess Intensity of Coronavirus Circulation
Science
CDSCO Expert Panel Gives Nod to Study on Mixing Doses of Covaxin, Covishield
Science
DCGI Expert Panel Recommends Against SII’s Proposal for Covovax Trial on Children
Science
